Sort
1,049,261 grants matching “t cell”
GENERAL CLINICAL RESEARCH CENTER
$3,429,552Duke University · M01 · FY2002 · RR
A Genomics Based Investigation of the Determinants of Polymicrobial Infectious Disease Outcomes
$3,428,670David A Rasko · University Of Maryland Baltimore · U19 · FY2022 · AI
Epigenetic Checkpoint Regulation of Naive T-cell Quiescence and Peripheral Tolerance
$3,428,212Yongqiang Feng · St. Jude Children'S Research Hospital · R01 · FY2025 · AI
Center for 3D Structure and Physics of the Genome
$3,427,788Job Dekker · Univ Of Massachusetts Med Sch Worcester · U54 · FY2015 · DK
Virulence Factors and Cell Death
$3,427,487Burnham Institute For Medical Research · P01 · FY2004 · AI
T-cell receptor gene therapy for cancer
$3,427,390Christian Hinrichs · Division Of Basic Sciences - Nci · ZIA · FY2020 · CA
Neurobiology and Cognitive Role of Slow Brain Network Fluctuations
$3,427,178Charles E Schroeder · Nathan S. Kline Institute For Psych Res · P50 · FY2023 · MH
Preclinical Translation of Kidney, Heart, and Lung Xenotransplantation
$3,426,920Richard N Pierson · Massachusetts General Hospital · U19 · FY2025 · AI
Cellular And Synaptic Physiology Of Hippocampal Interneurons
$3,426,623Chris J McBain · Eunice Kennedy Shriver National Institute Of Child Health & Human Development · ZIA · FY2009 · HD
Surgical IIH Treatment Trial
$3,426,258Mark J Kupersmith · Icahn School Of Medicine At Mount Sinai · U10 · FY2017 · EY
Canadian Cancer Trials Group - Canadian Collaborating Clinical Trials Network
$3,425,845Janet Ellen Dancey · Queen'S University At Kingston · U10 · FY2022 · CA
Genetic, Cellular and Molecular Mechanisms in Autoimmunity to Retina
$3,425,421Rachel R. Caspi · National Eye Institute · ZIA · FY2021 · EY
GENERAL CLINICAL RESEARCH CENTER
$3,425,357New York University School Of Medicine · M01 · FY2002 · RR
Experience-dependent regulation of dendrite morphogenesis and plasticity
$3,425,118Quan Yuan · National Institute Of Neurological Disorders And Stroke · ZIA · FY2020 · NS
Synthetic DNA & Novel Env Vaccine for HIV
$3,424,516David B. Weiner · Wistar Institute · U19 · FY2016 · AI
Post-Irradiation Intervention to Mitigate and Treat Non*
$3,424,278John E Moulder · Medical College Of Wisconsin · U19 · FY2006 · AI
IGERT: Multidisciplinary Graduate Progrqam in Biotechnology
$3,424,080Anne S Robinson · University Of Delaware · · FY2002 · EDU
Allogeneic and Autologous Immunotherapy for cancer and nonmalignant hematological disorders
$3,423,644Richard Childs · National Heart, Lung, And Blood Institute · ZIA · FY2025 · HL
Genetic Modification and Novel Cell Therapies in Non-Human Primate Hematopoietic Cells
$3,423,404So Gun Hong · National Heart, Lung, And Blood Institute · ZIA · FY2022 · HL
PDB MANAGEMENT BY THE RESEARCH COLLABORATORY FOR STRUCTURAL BIOINFORMATICS
$3,422,730Stephen K Burley · Rutgers, The State Univ Of N.J. · R01 · FY2021 · GM
Multicenter AIDS Cohort Study - Part B (Baltimore Center)
$3,422,677Joseph B. Margolick · Johns Hopkins University · U01 · FY2015 · AI
Orthopox immunization in patients with cancer or eczema
$3,422,012Dana-Farber Cancer Institute · U19 · FY2005 · AI
TTP and related proteins in the regulation of gene expression
$3,421,804Perry J Blackshear · National Institute Of Environmental Health Sciences · ZIA · FY2021 · ES
CD5-deleted chimeric antigen receptor cells (Senza5 CART5) to enhance immunotherapy against T cell non-Hodgkin lymphoma (NHL): a first-in-human phase I clinical trial
$3,421,591Stefan Klaus Barta · University Of Pennsylvania · R01 · FY2025 · FD
DEVELOPING THE FRAMEWORK FOR FIRST-IN-CLASS IMMUNOTHERAPIES THAT TARGET DISSEMINATED TUMOR CELLS AND PREVENT BREAST CANCER METASTASIS
$3,421,440Fred Hutchinson Cancer Center · · FY2020 · Defense Health Agency